1. bookVolume 1 (2017): Issue 2 (May 2017)
Journal Details
License
Format
Journal
eISSN
2564-615X
First Published
30 Jan 2017
Publication timeframe
4 times per year
Languages
English
Open Access

Epilobium angustifolium L.: A medicinal plant with therapeutic properties

Journal Details
License
Format
Journal
eISSN
2564-615X
First Published
30 Jan 2017
Publication timeframe
4 times per year
Languages
English
Abstract

Epilobium angustifolium L. is a medicinal plant belonging to the Onagraceae family, which includes more than 200 different species from all over the world. Traditional medicinal applications include treatment of prostate, gastrointestinal, menstrual disorders and recently it has been used for its analgesic and anti-inflammatory activity. In this investigation E. angustifolium was collected in Ternopil region of Ukraine. The obtained data demonstrated that E. angustifolium herb extract, rich in polyphenolic compounds such as flavonoids and tannins, display high antioxidant properties. In addition the potential anticancer activity has been investigated in vitro on human hepatocellular carcinoma cells (HepG2). Furthermore the cytotoxic and genotoxic effects of E. angustifolium have been investigated respectively by MTT and Comet assay. Results showed that at low concentration, up to 25 μg/mL, the cytotoxic effect was not observed. Increasing concentration from 50 to 75 μg/mL reduced significantly cell viability and induced an important DNA damage in hepatocellular carcinoma. These promising data were also confirmed with mitochondrial potential test. It is possible to conclude that E. angustifolium has beneficial properties in low concentration, in term of antioxidant activity, and it could be a potential antitumoral natural product if it will be used at high concentration

1. Newman DJ, Cragg GM. Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod 2016; 79(3): 629-661.10.1021/acs.jnatprod.5b01055Search in Google Scholar

2. De Sa Ferreira IC, Ferraro Vargas VM. Mutagenicity of medicinal plant extracts in Salmonella/microsome assay. Phytother Res 1998; 13(5): 397-400.10.1002/(SICI)1099-1573(199908/09)13:5<397::AID-PTR473>3.0.CO;2-#Search in Google Scholar

3. Celik TA, Aslanturk OS. Cytotoxic and genotoxic effects of Lavandula stoechas aqueous extracts. Biologia 2007; 62(3): 292-296.10.2478/s11756-007-0051-2Search in Google Scholar

4. Foster S, Duke JA. Eastern/Central Medicinal Plants and Herbs. Houghton Miflin Company, Boston 2000; 411. Search in Google Scholar

5. Tita B, Abdel-Haq H, Vitalone A, Mazzanti G, Saso L. Analgesic properties of Epilobium angustifolium, evaluated by the hot plate test and the writhing test. Farmaco 2001; 56(5-7): 341-343.10.1016/S0014-827X(01)01046-1Search in Google Scholar

6. Juan H, Sametz W, Hiermann A. Anti-inflammatory effects of a substance extracted from Epilobium angustifolium. Agents Actions 1988; 23(1-2): 106-107.10.1007/BF01967206Open DOISearch in Google Scholar

7. Hiermann A, Reidlinger M, Juan H, Sametz W. Isolation of the antiphlogistic principle from Epilobium angustifolium. Planta Med 1991;57(4): 357-360.10.1055/s-2006-960117Open DOISearch in Google Scholar

8. Vitalone A, Bordi F, Baldazzi C, Mazzanti G, Saso L, Tita B. Antiproliferative effect on a prostatic epithelial cell line (PZ-HPV-7) by Epilobium angustifolium L. Farmaco 2001; 56 (5-7): 483-489.10.1016/S0014-827X(01)01067-9Search in Google Scholar

9. Vitalone A, Guizzetti M, Costa LG, Tita B. Extracts of various species of Epilobium inhibit proliferation of human prostate cells. J Pharm Pharmacol 2003; 55(5): 683-690.10.1211/002235703765344603Open DOISearch in Google Scholar

10. Stolarczyk M, Naruszewicz M, Kiss AK. Extracts from Epilobium sp. herbs induce apoptosis in human hormone-dependent prostate cancer cells by activating the mitochondrial pathway. J Pharm Pharmacol 2013; 65(7): 1044-1054.10.1111/jphp.12063Search in Google Scholar

11. Chuyeshov V, Hohlova L, Lyapunova O. Industrial technology of drugs. Kharkiv: Golden Pages 2003; 720.Search in Google Scholar

12. Rashidinejad A, Birch EJ, Sun Waterhouse D, Everet DW. Effects of catechin on the phenolic content and antioxidant properties of low-fat cheese. Int J Food Sci Tech 2013; 48: 2448-2455.10.1111/ijfs.12234Open DOISearch in Google Scholar

13. Branciari R, Ranucci R, Trabalza-Marinucci M, Codini M, Orru M, Ortenzi R, Forte C, Ceccarini MR, Valiani A. Evaluation of the antioxidant properties and oxidative stability of Pecorino cheese made from the raw milk of ewes fed Rosmarinus officinalis L. leaves. Int J Food Sci Tech 2015; 50: 558-565.10.1111/ijfs.12712Search in Google Scholar

14. Prior RL, Hoang H, Gu L, Wu X, Bacchiocca M, Howard L, Hampsch- Woodill M, Huang D, Ou B, Jacob R. Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORACFL) of plasma and other biological and food samples. J Agr Food Chem 2003; 51(11): 3273-3279.10.1021/jf0262256Search in Google Scholar

15. Zulueta A, Maurizi A, Frigola A, Esteve MJ, Coli R, Burini G. Antioxidant capacity of cow milk, whey and deproteinized milk. Int Dairy J 2009; 19: 380-385.10.1016/j.idairyj.2009.02.003Open DOISearch in Google Scholar

16. Ceccarini MR, Vannini S, Cataldi S, Moretti M, Villarini M, Fioretti B, Albi E, Beccari T, Codini M. In Vitro Protective Effects of Lycium barbarum Berries Cultivated in Umbria (Italy) on Human Hepatocellular Carcinoma Cells. Biomed Res Int. 2016; 2016:7529521.10.1155/2016/7529521Search in Google Scholar

17. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89 (2): 271-277.10.1016/0022-1759(86)90368-6Search in Google Scholar

18. Ceccarini MR, Codini M, Cataldi S, Vannini S, Lazzarini A, Floridi A, Moretti M, Villarini M, Fioretti B, Beccari T, Albi E. Acid sphingomyelinase as target of Lycium Chinense: promising new action for cell health. Lipids Health Dis. 2016;15(1): 183.10.1186/s12944-016-0351-zOpen DOISearch in Google Scholar

19. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. Single cell gel/ comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 2000; 35(3): 206-221.10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-JOpen DOISearch in Google Scholar

20. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988; 175(1): 184-191.10.1016/0014-4827(88)90265-0Search in Google Scholar

21. Moretti M, Marcarelli M, Villarini M, Fatigoni C, Scassellati-Sforzolini G, Pasquini R. In vitro testing for genotoxicity of the herbicide terbutryn: cytogenetic and primary DNA damage. Toxicol In Vitro. 2002; 16(1):81-88.10.1016/S0887-2333(01)00092-3Open DOISearch in Google Scholar

22. Dominici L, Moretti M, Villarini M, Vannini S, Cenci G, Zampino C, Traina G. In vivo antigenotoxic properties of a commercial probiotic supplement containing bifidobacteria. Int J Probiotics and Prebiotics 2011; 6 (3-4): 179-186.Search in Google Scholar

23. Collins A R. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol. 2004; 26(3): 249-261.10.1385/MB:26:3:249Open DOISearch in Google Scholar

24. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 1997; 411(1): 77-82.10.1016/S0014-5793(97)00669-8Search in Google Scholar

25. Villarini M, Pagiotti R, Dominici L, Fatigoni C, Vannini S, Levorato S, Moretti M. Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare). J Nat Prod. 2014; 77(4):773-778.10.1021/np400653pSearch in Google Scholar

26. Nagata S. Apoptotic DNA fragmentation. Exp Cell Res 2000; 256(1): 12-18.10.1006/excr.2000.4834Search in Google Scholar

27. Nagata S, Nagase H, Kawane K, Mukae N, Fukuyama H. Degradation of chromosomal DNA during apoptosis. Cell Death Differ 2003; 10(1): 108-116.10.1038/sj.cdd.4401161Open DOISearch in Google Scholar

28. Kajstura M, Halicka HD, Pryjma J, Darzynkiewicz Z. Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete „sub-G1“ peaks on DNA content histograms. Cytometry A 2007; 71(3): 125-131.10.1002/cyto.a.20357Search in Google Scholar

29. Schepetkin IA, Ramstead AG, Kirpotina LN, Voyich JM, Jutila MA, Quinn MT. Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed). Phytother Res 2016; 30(8): 1287-1297.10.1002/ptr.5648Search in Google Scholar

30. Kiss AK, Bazylko A, Filipek A, Granica S, Jaszewska E, Kiarszys U, Kośmider A, Piwowarski J. Oenothein B’s contribution to the anti-inflammatory and antioxidant activity of Epilobium sp. Phytomedicine 2011; 18(7): 557-560.10.1016/j.phymed.2010.10.016Open DOISearch in Google Scholar

31. Kiss A, Kowalski J, Melzig MF. Effect of Epilobium angustifolium L. extracts and polyphenols on cell proliferation and neutral endopeptidase activity in selected cell lines. Pharmazie 2006; 61(1): 66-69.Search in Google Scholar

32. Kiss A, Kowalski J, Melzig MF. Compounds from Epilobium angustifolium inhibit the specific metallopeptidases ACE, NEP and APN. Planta Med 2004; 70(10): 919-923.10.1055/s-2004-832617Search in Google Scholar

33. Kiss A, Kowalski J, Melzig MF. Induction of neutral endopeptidase activity in PC-3 cells by an aqueous extract of Epilobium angustifolium L. and oenothein B. Phytomedicine 2006; 13(4): 284-289.10.1016/j.phymed.2004.08.002Open DOISearch in Google Scholar

34. Dehn PF, White CM, Conners DE, Shipkey G, Cumbo TA. Characterization of the human hepatocellular carcinoma (HepG2) cell line as an in vitro model for cadmium toxicity studies. In Vitro Cell Dev Biol Anim 2004; 40(5-6): 172-182.10.1290/1543-706X(2004)40<172:COTHHC>2.0.CO;2Search in Google Scholar

35. Xia JF, Gao JJ, Inagaki Y, Kokudo N, Nakata M, Tang W. Flavonoids as potential anti-hepatocellular carcinoma agents: recent approaches using HepG2 cell line. Drug Discov Ther 2013; 7(1): 1-8.10.5582/ddt.2013.v7.1.123524937Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo